title: Letter: the effects of rifaximin in hepatic encephalopathy--authors' reply.
authors.affiliation: Gastrounit, Medical Division, Copenhagen University Hospital Hvidovre, Hvidovre, Denmark; Department of Clinical Physiology and Nuclear Medicine, Copenhagen University Hospital Hvidovre, Hvidovre, Denmark. nina.kimer@regionh.dk.
authors.forename: N
authors.initials: N
authors.lastname: Kimer
authors.forename: A
authors.initials: A
authors.lastname: Krag
authors.forename: L L
authors.initials: LL
authors.lastname: Gluud
mesh_terms: D006501:Hepatic Encephalopathy / Q000188:drug therapy*; D006801:Humans; D020011:Protective Agents / Q000627:therapeutic use*; D012294:Rifamycins / Q000627:therapeutic use*
chemical_list: D020011:Protective Agents; D012294:Rifamycins